Are SL Green Realty Corp (SLG), Equinix Inc (EQIX) and Invivo Therapeutics Holdings Corp (NVIV) Worth Looking At In The Medium Term?

Posted by admin March 23, 2015 0 Comment 1047 views

New York, NY – GDP INSIDER  –  03/23/2015.

This article discusses three companies: SL Green Realty Corp (NYSE:SLG), Equinix Inc (NASDAQ:EQIX), Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV) and NYSE:SLG

SL Green Realty Corp (NYSE:SLG) continued its recent gains on Friday with the stock hitting a 52 week high of $135.81 before falling back slightly to close up 2.74% or $3.58 at $134.00 on very heavy trading of 16.474 million shares, compared to its three month average trading volume of 0.874 million. The stock began to rally after the board of directors approved the first quarter dividend of $0.60 per share of common stock and $0.40625 per share of Series I preferred stock. With RSI of 67.63 it may not go much higher but is a hold for now.

Do The Fundamentals Support More Growth In SL Green Realty Corp? Take A Closer Look With Free SLG Analysis.

Equinix Inc (NASDAQ:EQIX) bounced back from Thursday’s drop on Friday, gaining 1.29% or $3.05 to close at $238.95 on extremely active trading of 13.250 million shares compared to its three month average volume of 0.805 million. Friday represented the last day that the global interconnection and data center provider was traded on the S&P MidCap 400, as from today it has been officially added to the S&P 500. Whether its new placement in the S&P 500 will hurt or help the stock in the near term is debatable but it is certainly worth holding on to for now.

Will Equinix Inc’s Current Trend Help It Medium Term? Click Here For Free EQIX Analysis.

Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV) continued to climb on Friday with the stock closing up 13.98% or $0.355 at $2.895 with more than 2.064 million shares changing hands compared to its three month average trading volume of 1.137 million. The developer of new technological treatments of spinal cord injuries has been performing well so far this year with the stock up 83.54%, far outperforming the S&P 500 which is only up 2.39% for the same period. With the stock converging on a bullish MACD crossover, Invivo Therapeutics Holdings Corp is a solid hold and potential buy at this time.

Is Invivo Therapeutics Holdings Corp Overvalued? Review The Technical Indicators With Free NVIV Analysis

About UltimateStockAlerts provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word ULTIMATE to 555888 from your cell phone.

UltimateStockAlerts continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure:  UltimateStockAlerts is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit website, for complete risks and disclosures.

Write Your Comment